Arkolith/Insider Trading/TELO/Form 4

Aminov Erez

CEO and Chairman, DirectorTelomir Pharmaceuticals, Inc. (TELO) · full profile →Form 4 · filed May 30, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 28, 2025Grant(A)2.0M—$02.0M
May 28, 2025Grant(A)400K—$0400K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001641172-25-013148) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML